Michael Maes
Biological Psychiatry · 2005–2013
A researcher in the Science corpus: 7 papers; trusts 3 researchers and is trusted by 6 researchers here, as inferred from the citation graph.
Subfields
- Biological Psychiatry — 45 citations into it; #35 of 200 by trust here, #35 by citations
- Behavioral Neuroscience — 44 citations into it; #168 of 538 by trust here, #174 by citations
- Neurology — 21 citations into it; #492 of 1,455 by trust here, #961 by citations
- Cellular and Molecular Neuroscience — 18 citations into it
- Developmental Neuroscience — 17 citations into it
- Social Psychology — 5 citations into it; #7,764 of 15,694 by trust here, #6,804 by citations
Whom Michael Maes trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Michael Maes overall
- S. Salim
- George M. Slavich
- Michael R. Irwin
- Michael Berk
- B. Leonard
- P. Gałecki
- J. Kiecolt-Glaser
- Andrew H. Miller
- J. R. Kelly
- Brenda W. J. H. Penninx
Papers from Michael Maes's perspective
Ordered by how strongly the researchers Michael Maes trusts endorse each paper. Same corpus, a different order for every researcher.
- More hippocampal neurons in adult mice living in an enriched environment
- Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. (Biological Psychiatry)
- Depression: a case of neuronal life and death? (Biological Psychiatry)
- Chronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus
- Inflammatory Blockade Restores Adult Hippocampal Neurogenesis
- Inflammation is detrimental for neurogenesis in adult brain (Proceedings of the National Academy of Sciences of the United States of America)
- Endogenous kynurenines as targets for drug discovery and development (Nature reviews. Drug discovery)
- The inflammatory reflex (Nature)
- Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus
- The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine (Molecular Psychiatry)
Their papers
- Cytokines and major depression. (2005) — 1,270 citations
- The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression (2009) — 922 citations
- So depression is an inflammatory disease, but where does the inflammation come from? (2013) — 1,280 citations
- Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. (2012) — 781 citations
- The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. (2011) — 665 citations
- A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. (2011) — 1,147 citations
- The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. (2008) — 594 citations